Turkish validation of a questionnaire to measure parents' knowledge and attitudes about preventing toxic chemical harm to children
Official title: Turkish Validity and Reliability Study of PRevention of Toxic Chemicals in the Environment for Children Tool (PRoTECT)
Run by Istanbul University - Cerrahpasa · NCT07483606 · Data updated 2026-11-12
This project will test a Turkish questionnaire for parents and future parents to measure their knowledge and attitudes about preventing children's exposure to toxic chemicals.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 204 (estimated) |
| Sponsor | Istanbul University - Cerrahpasa Academic / other |
| Locations | 1 site (Istanbul, AVCILAR) |
| Status | Recruiting |
| Started | March 16, 2026 |
| Main results expected | April 3, 2026 |
| Study ends | May 4, 2026 |
| Registry record updated | March 19, 2026 |
| Trial ID | NCT07483606 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Literate adults who are parents or planning to become parents and can read Turkish and consent to participate are ideal candidates.
✕Probably not a fit
People who are illiterate, do not read Turkish, or are not parents/prospective parents are unlikely to benefit from participating.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project adapts and validates the "Prevention of Toxic Chemicals in the Environment for Children" questionnaire for Turkish-speaking parents and prospective parents. Literate adults will complete the survey at the Istanbul University–Cerrahpasa site in Avcılar, and responses will be analyzed for reliability and validity. Psychometric methods will likely include internal consistency, test–retest reliability, and construct/content validity checks. The goal is to produce a culturally appropriate, reliable measurement tool to gauge parental knowledge and attitudes about environmental toxicants.
Why it matters
Potential benefit: If successful, the tool could help identify gaps in parental knowledge so public health programs can better target education to reduce children’s exposure to toxic chemicals.
How similar studies have gone: Similar parental knowledge and attitude questionnaires have been translated and validated in other languages and generally demonstrate acceptable reliability after cultural adaptation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Adult parents and prospective parents Exclusion Criteria: Illiterate
Where it's running
-
Rukiye Duman
Istanbul, Avcilar, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Ruki̇ye Duman Research Assistant
- Email: rukiye.duman@iuc.edu.tr
- Phone: +90 5530315895
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How age affects germinal center responses after flu and rabies vaccines
Researchers will test how the immune system responds to flu and rabies vaccines in younger adults (18–40) and older adults (65+).
-
Magnetic field maps with NV sensors for non-invasive heart measurements
This study tests whether diamond-based NV magnetometers can non-invasively detect and map the heart's magnetic field in healthy adults.
-
Methylation analyses using home-based self-sampling in women with and without gynecological disease
This study tests whether self-collected urine and vaginal samples can reveal DNA methylation markers that distinguish people with gynecological (pre-)cancers from cancer-free controls.
-
Omega-3 status in healthy adults: comparing different fish-oil and algae-oil products
This study tests whether various fish-oil and algae-oil products can raise the Omega-3 Index in healthy adults who don’t eat much fatty fish.
-
A safe, carefully dosed test of TBD11 in healthy adults
This phase 1 study tests TBD11 in healthy adults to see if it is safe and tolerable and to understand how it behaves in the body, including how it interacts with other medicines.
-
Fosmanogepix in healthy adults: how it may interact with other drugs and heart rhythm
This study tests whether fosmanogepix (and its active form manogepix) changes how other medicines work in healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.